RYTM

Setmelanotide

Leptin Receptor Deficiency Obesity

NDA Filing

Exp Date

Late-4Q 2019 / early-1Q 2020

Amp Volatility Score

36%

Catalyst Info & Data Links

Potential Catalyst Events:

  • NDA submission for setmelanotide in LEPR deficiency obesity.

 

Prior Data Links:

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

PROUDLY CREATED WITH WIX.COM

  • Twitter Social Icon
  • LinkedIn Social Icon